227 related articles for article (PubMed ID: 32548120)
21. FKBP12-immunopositive inclusions in patients with α-synucleinopathies.
Honjo Y; Ayaki T; Horibe T; Ito H; Takahashi R; Kawakami K
Brain Res; 2018 Feb; 1680():39-45. PubMed ID: 29246765
[TBL] [Abstract][Full Text] [Related]
22. The role of α-synuclein in neurotransmission and synaptic plasticity.
Cheng F; Vivacqua G; Yu S
J Chem Neuroanat; 2011 Dec; 42(4):242-8. PubMed ID: 21167933
[TBL] [Abstract][Full Text] [Related]
23. Abundance of Synaptic Vesicle-Related Proteins in Alpha-Synuclein-Containing Protein Inclusions Suggests a Targeted Formation Mechanism.
McCormack A; Keating DJ; Chegeni N; Colella A; Wang JJ; Chataway T
Neurotox Res; 2019 May; 35(4):883-897. PubMed ID: 30796693
[TBL] [Abstract][Full Text] [Related]
24. α-Synuclein at the Presynaptic Axon Terminal as a Double-Edged Sword.
Tan LY; Tang KH; Lim LYY; Ong JX; Park H; Jung S
Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454096
[TBL] [Abstract][Full Text] [Related]
25. Higher levels of myelin phospholipids in brains of neuronal α-Synuclein transgenic mice precede myelin loss.
Grigoletto J; Pukaß K; Gamliel A; Davidi D; Katz-Brull R; Richter-Landsberg C; Sharon R
Acta Neuropathol Commun; 2017 May; 5(1):37. PubMed ID: 28482862
[TBL] [Abstract][Full Text] [Related]
26. Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson's Disease.
Mori A; Imai Y; Hattori N
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32392751
[TBL] [Abstract][Full Text] [Related]
27. Neutral lysophosphatidylcholine mediates α-synuclein-induced synaptic vesicle clustering.
Lai Y; Zhao C; Tian Z; Wang C; Fan J; Hu X; Tu J; Li T; Leitz J; Pfuetzner RA; Liu Z; Zhang S; Su Z; Burré J; Li D; Südhof TC; Zhu ZJ; Liu C; Brunger AT; Diao J
Proc Natl Acad Sci U S A; 2023 Oct; 120(44):e2310174120. PubMed ID: 37883437
[TBL] [Abstract][Full Text] [Related]
28. Cortico-amygdala synaptic structural abnormalities produced by templated aggregation of α-synuclein.
Gcwensa NZ; Russell DL; Long KY; Brzozowski CF; Liu X; Gamble KL; Cowell RM; Volpicelli-Daley LA
bioRxiv; 2024 May; ():. PubMed ID: 38798467
[TBL] [Abstract][Full Text] [Related]
29. The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease.
Benskey MJ; Perez RG; Manfredsson FP
J Neurochem; 2016 May; 137(3):331-59. PubMed ID: 26852372
[TBL] [Abstract][Full Text] [Related]
30. Neuropathology of synuclein aggregates.
Duda JE; Lee VM; Trojanowski JQ
J Neurosci Res; 2000 Jul; 61(2):121-7. PubMed ID: 10878583
[TBL] [Abstract][Full Text] [Related]
31. α-Synuclein may cross-bridge v-SNARE and acidic phospholipids to facilitate SNARE-dependent vesicle docking.
Lou X; Kim J; Hawk BJ; Shin YK
Biochem J; 2017 Jun; 474(12):2039-2049. PubMed ID: 28495859
[TBL] [Abstract][Full Text] [Related]
32. Cholesterol in Synaptic Vesicle Membranes Regulates the Vesicle-Binding, Function, and Aggregation of α-Synuclein.
Mahapatra A; Mandal N; Chattopadhyay K
J Phys Chem B; 2021 Oct; 125(40):11099-11111. PubMed ID: 34473498
[TBL] [Abstract][Full Text] [Related]
33. From Synaptic Protein to Prion: The Long and Controversial Journey of α-Synuclein.
Heras-Garvin A; Stefanova N
Front Synaptic Neurosci; 2020; 12():584536. PubMed ID: 33071772
[TBL] [Abstract][Full Text] [Related]
34. Identification of an Alternatively Spliced α-Synuclein Isoform That Generates a 41-Amino Acid N-Terminal Truncated Peptide, 41-syn: Role in Dopamine Homeostasis.
Vinnakota RL; Yedlapudi D; Manda KM; Bhamidipati K; Bommakanti KT; RangaLakshmi GS; Kalivendi SV
ACS Chem Neurosci; 2018 Dec; 9(12):2948-2958. PubMed ID: 29996045
[TBL] [Abstract][Full Text] [Related]
35. Alpha-Synuclein and Lipids: The Elephant in the Room?
Sarchione A; Marchand A; Taymans JM; Chartier-Harlin MC
Cells; 2021 Sep; 10(9):. PubMed ID: 34572099
[TBL] [Abstract][Full Text] [Related]
36. Protein kinase R dependent phosphorylation of α-synuclein regulates its membrane binding and aggregation.
Reimer L; Gram H; Jensen NM; Betzer C; Yang L; Jin L; Shi M; Boudeffa D; Fusco G; De Simone A; Kirik D; Lashuel HA; Zhang J; Jensen PH
PNAS Nexus; 2022 Nov; 1(5):pgac259. PubMed ID: 36712380
[TBL] [Abstract][Full Text] [Related]
37. Functional cooperation of α-synuclein and VAMP2 in synaptic vesicle recycling.
Sun J; Wang L; Bao H; Premi S; Das U; Chapman ER; Roy S
Proc Natl Acad Sci U S A; 2019 Jun; 116(23):11113-11115. PubMed ID: 31110017
[TBL] [Abstract][Full Text] [Related]
38. Sequestration of synaptic proteins by alpha-synuclein aggregates leading to neurotoxicity is inhibited by small peptide.
Choi MG; Kim MJ; Kim DG; Yu R; Jang YN; Oh WJ
PLoS One; 2018; 13(4):e0195339. PubMed ID: 29608598
[TBL] [Abstract][Full Text] [Related]
39. Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease.
Frahm S; Melis V; Horsley D; Rickard JE; Riedel G; Fadda P; Scherma M; Harrington CR; Wischik CM; Theuring F; Schwab K
Behav Brain Res; 2018 Feb; 339():153-168. PubMed ID: 29180135
[TBL] [Abstract][Full Text] [Related]
40. Detecting Alpha Synuclein Seeding Activity in Formaldehyde-Fixed MSA Patient Tissue by PMCA.
Becker K; Wang X; Vander Stel K; Chu Y; Kordower J; Ma J
Mol Neurobiol; 2018 Nov; 55(11):8728-8737. PubMed ID: 29589283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
